24th May 2024

Initial orders of the Genedrive MT-RNR1 Products for new sites in the UK

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to anno...

21st May 2024

Key CYP2C19 ID test performance milestone achieved

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to anno...

3rd Apr 2024

NICE recommends the Genedrive® CYP2C19-ID Kit

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces that the...